1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Investigational New Drug Contract Development and Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Contract Development
1.2.3 Contract Manufacturing
1.3 Market by Application
1.3.1 Global Investigational New Drug Contract Development and Manufacturing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Investigational New Drug Contract Development and Manufacturing Market Perspective (2017-2028)
2.2 Investigational New Drug Contract Development and Manufacturing Growth Trends by Region
2.2.1 Investigational New Drug Contract Development and Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Investigational New Drug Contract Development and Manufacturing Historic Market Size by Region (2017-2022)
2.2.3 Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Region (2023-2028)
2.3 Investigational New Drug Contract Development and Manufacturing Market Dynamics
2.3.1 Investigational New Drug Contract Development and Manufacturing Industry Trends
2.3.2 Investigational New Drug Contract Development and Manufacturing Market Drivers
2.3.3 Investigational New Drug Contract Development and Manufacturing Market Challenges
2.3.4 Investigational New Drug Contract Development and Manufacturing Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Investigational New Drug Contract Development and Manufacturing Players by Revenue
3.1.1 Global Top Investigational New Drug Contract Development and Manufacturing Players by Revenue (2017-2022)
3.1.2 Global Investigational New Drug Contract Development and Manufacturing Revenue Market Share by Players (2017-2022)
3.2 Global Investigational New Drug Contract Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Investigational New Drug Contract Development and Manufacturing Revenue
3.4 Global Investigational New Drug Contract Development and Manufacturing Market Concentration Ratio
3.4.1 Global Investigational New Drug Contract Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Investigational New Drug Contract Development and Manufacturing Revenue in 2021
3.5 Investigational New Drug Contract Development and Manufacturing Key Players Head office and Area Served
3.6 Key Players Investigational New Drug Contract Development and Manufacturing Product Solution and Service
3.7 Date of Enter into Investigational New Drug Contract Development and Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Investigational New Drug Contract Development and Manufacturing Breakdown Data by Type
4.1 Global Investigational New Drug Contract Development and Manufacturing Historic Market Size by Type (2017-2022)
4.2 Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Type (2023-2028) 5 Investigational New Drug Contract Development and Manufacturing Breakdown Data by Application
5.1 Global Investigational New Drug Contract Development and Manufacturing Historic Market Size by Application (2017-2022)
5.2 Global Investigational New Drug Contract Development and Manufacturing Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
6.2 North America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
6.3 North America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
7.2 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
7.3 Europe Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
8.2 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
8.3 Asia-Pacific Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
9.2 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
9.3 Latin America Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size (2017-2028)
10.2 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country (2017-2022)
10.3 Middle East & Africa Investigational New Drug Contract Development and Manufacturing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 Covance Inc.
11.1.1 Covance Inc. Company Detail
11.1.2 Covance Inc. Business Overview
11.1.3 Covance Inc. Investigational New Drug Contract Development and Manufacturing Introduction
11.1.4 Covance Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.1.5 Covance Inc. Recent Development
11.2 Charles River Laboratories Inc.
11.2.1 Charles River Laboratories Inc. Company Detail
11.2.2 Charles River Laboratories Inc. Business Overview
11.2.3 Charles River Laboratories Inc. Investigational New Drug Contract Development and Manufacturing Introduction
11.2.4 Charles River Laboratories Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.2.5 Charles River Laboratories Inc. Recent Development
11.3 Cambrex Corporation
11.3.1 Cambrex Corporation Company Detail
11.3.2 Cambrex Corporation Business Overview
11.3.3 Cambrex Corporation Investigational New Drug Contract Development and Manufacturing Introduction
11.3.4 Cambrex Corporation Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.3.5 Cambrex Corporation Recent Development
11.4 IQVIA Holdings Inc.
11.4.1 IQVIA Holdings Inc. Company Detail
11.4.2 IQVIA Holdings Inc. Business Overview
11.4.3 IQVIA Holdings Inc. Investigational New Drug Contract Development and Manufacturing Introduction
11.4.4 IQVIA Holdings Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.4.5 IQVIA Holdings Inc. Recent Development
11.5 Syneos Health
11.5.1 Syneos Health Company Detail
11.5.2 Syneos Health Business Overview
11.5.3 Syneos Health Investigational New Drug Contract Development and Manufacturing Introduction
11.5.4 Syneos Health Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.5.5 Syneos Health Recent Development
11.6 Lonza
11.6.1 Lonza Company Detail
11.6.2 Lonza Business Overview
11.6.3 Lonza Investigational New Drug Contract Development and Manufacturing Introduction
11.6.4 Lonza Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.6.5 Lonza Recent Development
11.7 Catalent
11.7.1 Catalent Company Detail
11.7.2 Catalent Business Overview
11.7.3 Catalent Investigational New Drug Contract Development and Manufacturing Introduction
11.7.4 Catalent Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.7.5 Catalent Recent Development
11.8 Recipharm AB
11.8.1 Recipharm AB Company Detail
11.8.2 Recipharm AB Business Overview
11.8.3 Recipharm AB Investigational New Drug Contract Development and Manufacturing Introduction
11.8.4 Recipharm AB Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.8.5 Recipharm AB Recent Development
11.9 Siegfried Holding AG
11.9.1 Siegfried Holding AG Company Detail
11.9.2 Siegfried Holding AG Business Overview
11.9.3 Siegfried Holding AG Investigational New Drug Contract Development and Manufacturing Introduction
11.9.4 Siegfried Holding AG Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.9.5 Siegfried Holding AG Recent Development
11.10 Thermo Fisher Scientific Inc.
11.10.1 Thermo Fisher Scientific Inc. Company Detail
11.10.2 Thermo Fisher Scientific Inc. Business Overview
11.10.3 Thermo Fisher Scientific Inc. Investigational New Drug Contract Development and Manufacturing Introduction
11.10.4 Thermo Fisher Scientific Inc. Revenue in Investigational New Drug Contract Development and Manufacturing Business (2017-2022)
11.10.5 Thermo Fisher Scientific Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
